Anti-VEGF therapy induces ECM remodeling and mechanical barriers to therapy in colorectal cancer liver metastases
Nuh N. Rahbari(Technische Universität Dresden), Dai Fukumura(Massachusetts General Hospital), Keehoon Jung(National University College), Jürgen Weitz(University Hospital Carl Gustav Carus), Takahiro Heishi(Harvard University), Hadi T. Nia(Boston University), Dan G. Duda(Harvard University), Yves Boucher(Harvard University), Julien Daubriac(Harvard University), João Incio(Harvard University), John D. Martin(Harvard University), Christoph Reißfelder(Technische Universität Dresden), Dmitriy Kedrin(Allen Institute), William W. Ho(Harvard University), Yuhui Huang(Soochow University), Ivy Chen(Harvard University), Christina M. Edrich(Harvard University), Jeffrey W. Clark(Massachusetts General Hospital), Nir Maimon(Harvard University), Hao Liu(Shihezi University), Alan J. Grodzinsky(Massachusetts Institute of Technology)
Cited by 254
Related Papers
Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2010|4.5k
Posthepatectomy liver failure: A definition and grading by the International Study Group of Liver Surgery (ISGLS)
|Surgery|2011|2.3k
Crizotinib in <i>ROS1</i>-Rearranged Non–Small-Cell Lung Cancer
|New England Journal of Medicine|2014|2k